title: Tetracyclines and pain.
abstract: Tetracyclines are natural or semi-synthetic bacteriostatic agents which have been used since late 1940s against a wide range of gram-positive and gram-negative bacteria and atypical organisms such as chlamydia, mycoplasmas, rickettsia, and protozoan parasites. After the discovery of the first tetracyclines, a second generation of compounds was sought in order to improve water solubility for parenteral administration or to enhance bioavailability after oral administration. This approach resulted in the development of doxycycline and minocycline in the 1970s. Doxycycline was included in the World Health Organization Model List of Essential Medicines either as antibacterial or to prevent malaria or to treat patients with this disease. Additional development led to the third generation of tetracyclines, being tigecycline the only medicine of this class to date. Besides antibacterial activities, the anti-inflammatory, antihypernociceptive and neuroprotective activities of tetracyclines began to be widely studied in the late 1990s. Indeed, there has been an increasing interest in investigating the effects induced by minocycline as this liposoluble derivative is known to cross the blood-brain barrier to the greatest extent. Minocycline induces antihypernociceptive effects in a wide range of animal models of nociceptive, inflammatory and neuropathic pain. In this study, we discuss the antihypernociceptive activity of tetracyclines and summarise its underlying cellular and molecular mechanisms.
authors.affiliation: Departamento de Fisiologia e Biofísica, Instituto de Ciências Biológicas (ICB), Bloco A4, Sala 168, Universidade Federal de Minas Gerais (UFMG), Avenida Antônio Carlos 6627, 31270-901, Belo Horizonte, Brazil. silvabastos@ufmg.br
authors.forename: Leandro F S
authors.initials: LF
authors.lastname: Bastos
authors.forename: Antônio C P
authors.initials: AC
authors.lastname: de Oliveira
authors.forename: Linda R
authors.initials: LR
authors.lastname: Watkins
authors.forename: Márcio F D
authors.initials: MF
authors.lastname: Moraes
authors.forename: Márcio M
authors.initials: MM
authors.lastname: Coelho
mesh_terms: D000700:Analgesics / Q000627:therapeutic use*; D000818:Animals; D006801:Humans; D010146:Pain / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D013754:Tetracyclines / Q000627:therapeutic use*
chemical_list: D000700:Analgesics; D013754:Tetracyclines